Rib-X
AcquiredRib-X was founded in 2000, is headquartered in New Haven, United States, and has $209.5M in recorded funding across 5 rounds.
- Headquarters
- New Haven, Connecticut
- Founded
- 2000
- Business Model
- B2B
- Total Funding
- $209.5M
- Last Round
- $70.0M Venture RoundFeb 2014
- Rounds
- 5
- Acquisition Date
- Sep 2025
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 2 investors for this company. The full record is or through the API.
About
Rib-X Pharmaceuticals was an American biopharmaceutical company founded in 2000 in New Haven, Connecticut, focused on the structure-based design and development of novel broad-spectrum antibiotics to treat antibiotic-resistant infections in hospital settings. Its lead candidate, delafloxacin, was later named one of R&D Directions' 100 great investigational drugs of 2009. The company was renamed Melinta Therapeutics in 2013.
Summary
Rib-X is a Biotech company based in New Haven, United States, founded in 2000. It has raised $209.5M in total across 5 rounds, most recently a $70.0M Venture Round in Feb 2014. Investors include SR One and Euclid SR Partners.
Funding & Exit History
Sep 2025
Sign up to see all 6 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rib-x"><img src="https://indexed.vc/api/badge/company/rib-x" alt="Rib-X on Indexed.vc" width="260" height="76" /></a>